CLL/SLL SoC clinical trials

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

This study is testing a new medicine, JNJ-95804306, for people with certain blood cancers like acute myeloid leukemia (AML) or chronic lymphocytic leukemia (CLL) that have come back or not responded to previous treatments. It aims to find a safe dose and see how well it works.